Vigabatrin in the treatment of epilepsy: A long-term follow-up study

A. Tartara, R. Manni, C. A. Galimberti, J. P. Mumford, A. Iudice, E. Perucca

Research output: Contribution to journalArticlepeer-review

Abstract

Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.

Original languageEnglish
Pages (from-to)467-471
Number of pages5
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume52
Issue number4
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Fingerprint Dive into the research topics of 'Vigabatrin in the treatment of epilepsy: A long-term follow-up study'. Together they form a unique fingerprint.

Cite this